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Abstract
Kisspeptins (KPs) are major regulators of trophoblast and cancer invasion. Thus far, limited
and conflicting data are available on KP-mediated modulation of breast cancer (BC) metas-
tasis; mostly based on synthetic KP-10, the most active fragment of KP. Here, we report for
the first time comprehensive functional effects of term placental KPs on proliferation, adhe-
sion, Matrigel invasion, motility, MMP activity and pro-inflammatory cytokine production in
MDA-MB-231 (estrogen receptor-negative) and MCF-7 (estrogen receptor-positive). KPs
were expressed at high level by term placental syncytiotrophoblasts and released in soluble
form. Placental explant conditioned medium containing KPs (CM) significantly reduced pro-
liferation of both cell types compared to CM without (w/o) KP (CM-w/o KP) in a dose- and
time-dependent manner. In MDA-MB-231 cells, placental KPs significantly reduced adhe-
sive properties, while increased MMP9 and MMP2 activity and stimulated invasion.
Increased invasiveness of MDA-MB-231 cells after CM treatment was inhibited by KP
receptor antagonist, P-234. CM significantly reduced motility of MCF-7 cells at all time
points (2–30 hr), while it stimulated motility of MDA-MB-231 cells. These effects were
reversed by P-234. Co-treatment with selective ER modulators, Tamoxifen and Raloxifene,
inhibited the effect of CM on motility of MCF-7 cells. The level of IL-6 in supernatant of MCF-
7 cells treated with CM was higher compared to those treated with CM-w/o KP. Both cell
types produced more IL-8 after treatment with CM compared to those treated with CM-w/o
KP. Taken together, our observations suggest that placental KPs differentially modulate
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vital parameters of estrogen receptor-positive and -negative BC cells possibly through mod-
ulation of pro-inflammatory cytokine production.
Introduction
Invasion of placental trophoblast cells into the maternal uterine decidua and vasculature is the
hallmark of haemochorial placentation. During placental development and differentiation,
extravillous trophoblasts (EVT) undergo substantial molecular modifications exemplified by
the over expression of matrix metalloproteinases (MMPs) and gain the ability to invade extra-
cellular matrix. From biological point of view, trophoblast invasion shares common features
with tumor invasion and metastasis with similar molecular machinery and mechanisms. In
both trophoblast and cancer cells, acquisition of invasive phenotype is accompanied by several
coordinated events including repression of specific cell adhesion molecules, augmentation of
cell motility, expression of MMPs and proto-oncogene products and establishment of immu-
nosuppressive environmental conditions[1–3].
In spite of aforesaid similarities and contrary to tumor cells, trophoblast invasion is under
tight spatiotemporal control[4]. Such controlled invasion is of crucial importance for maternal
health and growing fetus development. In this context, several autocrine and paracrine regula-
tory systems work in concert to limit trophoblast invasion. Gonadotropin releasing hormone
(GnRH) and tumor necrosis factor (TNF)-alpha are among the factors derived from placenta
and exert considerable inhibitory action on trophoblast migration and invasion[5, 6].
Kisspeptins (KPs) are major regulator of trophoblast invasion[7]. This family of regulatory
peptides is originated from the KISS1 gene translation product following proteolytic process-
ing. The largest form, also known as KISS1, consists of 145 amino acids[8], which are processed
by proteolytic enzymes to shorter fragments of 54 (KP-54; metastin), 14 (KP-14), 13 (KP-13)
or 10 (KP-10) amino acids. The common feature of all KPs is a C-terminal ten residue peptide
(KP-10) necessary for receptor activation[7]. KPs exert their regulatory actions after binding to
their cognate receptor, KISS1R[9]. Among all KPs, KP-10 has the highest potency to bind
KISS1R and to trigger downstream signaling pathway[10]. In trophoblasts of early placenta, it
was shown that only KP-10 was able to increase intracellular Ca2+[7, 11]. KISS1R activation
following KP binding results in activation of phospholipase C, phosphatidylinositol turnover,
calcium mobilization, and stimulation of extracellular signal-regulated kinase-1 and -2 (ERK1
and ERK2) and mitogen-activated protein (MAPKs)[8–10].
In addition to placenta, KISS1 transcript is also expressed at high levels in other tissues
including brain, breast, pancreas, testis, liver, heart and small intestine. In line with its auto-
crine action, KISS1RmRNA displays similar tissue distribution as KISS1transcript. KISS1/
KISS1R system has also been shown to be active in many cancer cell types with profound anti-
metastatic action[12, 13].
In case of breast cancer, the data on potential action of KISS1 on invasiveness and metastasis
is rather controversial. As with anti-metastatic action in melanoma cell lines C8161 and Mel-
JuSo, initially it was shown that KISS1 acts as a metastasis suppressor in human breast cancer
cells, MDA-MB-435[14]. More recent studies highlighted the positive correlation of KISS1/
KISS1R system with breast cancer progression and patient prognosis[15]. Moreover, expres-
sion of KISS1 was higher in patients who had died from breast cancer than those who had sur-
vived[16]. Indeed, higher expression levels of KISS1 and KISS1R was found to be positively
correlated with shorter relapse-free survival[15]. The clue for such discrepancy was proposed
by Cvetkovic´ et al. who clearly showed that it is the ER status of mammary cells that dictates
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KP responsiveness. Besides the effect of endogenous KISS1 expression by breast cancer cells on
their own vital parameters including proliferation and invasion, exogenous KISS1 may also
alter invasive capacity of tumor cells [17]. It is proposed that placental factors facilitate motility
of some breast cancer cell lines and thus contribute to the advanced breast cancer found during
pregnancy [18].
Thus far, almost all the data on potential action of KPs over vital parameters of cancer cells
has been derived from the experiments in which synthetic KP-10 has been used. To have a bet-
ter understanding of functional activity of the native molecule, one may need to know how
cancerous activity of malignant cells is affected by the KPs released from its physiological
sources such as placenta. To this end, we embarked on comprehensive analyses of the potential
effects of placental KPs and synthetic KP-10 on proliferation, adhesion, invasion, migration,
MMP activity and pro-inflammatory cytokine production in ER- (MDA-MB-231) and ER+
(MCF-7) breast cancer cells.
Materials and Methods
Placental unit collection
All experimental procedures listed in this research work was conducted after being approved
by ethical committee of Avicenna Research Institute (92.1630) in accordance with Helsinki
guidelines and regulations and all participants signed a written consent form before enrolment
in this study. From eleven healthy women (22 to 32 years) with uncomplicated term pregnan-
cies undergoing elective cesarean, placentas were obtained, suspended in culture medium and
immediately transferred to the laboratory in a cold chain under sterile condition. Before cesar-
ean, all women were examined for such blood born viral infections as HIV, HBV and HCV
and checked to make sure they did not have vaginal infection.
Isolation of term placental cytotrophoblast cells
All experimental procedures were carried out under sterile conditions. Isolation of cytotropho-
blasts was performed according to the protocol published elsewhere[19]. In brief, placentas
were placed in a sterile stainless steel dish under biological hood with maternal side of the pla-
centa facing up. About 50 g of villous tissue was carefully removed using scissors and forceps
and placed in a sterile beaker. Tissue fragments were rinsed several times by phosphate buff-
ered saline to remove blood clots. Tissues were then transferred to a 150 mm culture plate and
minced finely with scissors. Obtained small fragments were rinsed again over cell dissociation
sieve and digested in three successive steps, each for 15–20 min, at 37°C in an enzymatic cock-
tail containing DNase (Roche, Germany) and Trypsin (Sigma, USA). After collecting the cells
from all three digestion stages, cell suspensions were pooled and filtered using a 100 μm nylon
cell strainer. The resulting cells were layered over preformed Percoll (GE Healthcare, Sweden)
gradient (5–70%). Upper diffuse band (ﬃ1.046–1.065) was collected as cytotrophoblast cells
and washed three times with RPMI.
Immunofluorescent staining of placental tissues, purified
cytotrophoblasts and breast cancer cells
Detection of KPs and cytokeratin 7 (CK7) was performed by Immunofluorescent staining[20].
In brief, small fragments of placental tissue were fixed for 48 hr in 10% formalin, embedded in
paraffin and cut into 4 μm sections. Slides were then deparaffinized in xylene, hydrated in
increasing grade of ethanol and rinsed several times in tap water. Antigen retrieval was per-
formed in 95°C heated Tris-EDTA (10mM) buffer for 30 min. After blocking of non-specific
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binding sites by 5% non-immune sheep serum, 1:1000 dilution of purified rabbit anti-human
KP-54 was applied to the slides for 90 min at room temperature (RT). Slides were then washed
in PBS containing 1% bovine serum albumin (PBS-BSA) three times and incubated in Dylight
488-goat anti-rabbit (1:800) for 90 minutes at RT in the dark. All subsequent incubation steps
were done in the dark. Washing step was proceeded as above followed by incubation with
1:800 dilution of mouse anti-human CK7 for 30 min. After washing, slides were treated with
CY3- goat anti-mouse (1:800) for 45 min (all antibodies were generously gifted by Department
of Cell Biology, Histology and Embryology, Medical University of Graz). Nuclei were visualized
by diamidino-2-phenylindole (DAPI) staining for 5 min. At the final step, slides were washed,
mounted with PBS-glycerol (50% v/v) and inspected under epifluorescent microscope
equipped with DP70 CCD camera (Olympus, Japan). Single color KPs staining of purified
cytotrophoblasts and breast cancer cells was performed as above with some modifications[21].
Briefly, cells were cytospinned on poly-L-lysine-coated slides, dried at RT for 15 min and fixed
in ice-cold pure acetone for 5 min. After three washes, primary and secondary antibodies were
applied at aforesaid concentrations and slides were processed as above. In negative controls,
primary antibodies were substituted by non-immune sera from rabbit or mouse.
Culture of placental villous tissue explants
With maternal side of placenta facing up, 3–5 mm fragments of cotyledons were dissected
using forceps and scissors and placed in petri dish containing PBS. The villous tissue was then
carefully isolated and cut into similar fragments of about 5 mg and four pieces were placed in
each well of 24-well plates coated with matrigel (BD Biosciences, USA). Plate was incubated at
37°C CO2 incubator for 3 hr for initial attachment. After then, 300 μl serum-free
DMEM-Ham0s F12 (PAA, Germany) supplemented with 2 mM L-glutamine, 100 IU/mL peni-
cillin and 100 μg/mL streptomycin was slowly added to each well and incubation was contin-
ued for further 2–72 hr. At different time points from one to72 hr, culture supernatants were
collected and examined for the content of KPs released from placental explants by Western
blotting as described below. Based on the results, all subsequent culture supernatants were col-
lected 4 hr after addition of culture medium, centrifuged and stored at -80°C as conditioned
medium (CM).
Cell Culture
Human breast carcinoma cells, MDA-MB-231 andMCF-7 cell lines were purchased from
national cell bank of Iran (NCBI, Tehran, Iran) and cultured in DMEM (Gibco, USA) supple-
mented with 5% (v/v) fetal bovine serum (FBS) (Gibco), 2 mM L-glutamine, 100 IU/mL penicil-
lin and 100 μg/mL streptomycin. Cells were maintained in culture not more than three passages.
Reverse transcriptase polymerase chain reaction (RT-PCR)
Total RNA fromMDA-MB-231 and MCF-7 cells was extracted using RNeasy kit (Thermo Sci-
entific, Lithuania) according to the manufacturer’s instructions. RNA concentration was mea-
sured at 260/280 nm and its quality was evaluated by gel electrophoresis. cDNA synthesis and
RT-PCR was performed as described elsewhere[22]. Briefly, purified RNA was heated to 65°C
and immediately cooled on ice. cDNAMix containing 2 μg RNA, 5× buffer (Fermentase, Vil-
nius, Lithuania), 2 mM dNTP mix (Roche, Penzberg, Germany), 2 mM Random hexamer
(Cybergene, Stockholm, Sweden), and 20 U⁄mL RTM-MuLV (Fermentase) was incubated for
60 min at 42°C. One μL cDNA and 1 μL of each pair of primers equivalent to the final concen-
trations of 0.4 pM for β-actin (as loading control) and 0.2 pM for KISS1, KISS1R, ERα and ERβ
were added to 12.5 μL of ready to use master mix (Ampliqon, Denmark). Sequence, amplicon
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size and Tm of each primer set for KISS1, KISS1R, ERα, ERβ and β-actin have been summarized
in Table 1. For all PCR programs, temperatures of 94°C and 72°C were applied for denaturation
and extension for 30 seconds followed by final extension for 7 min. PCR was performed 30 (for
β-actin) or 35 cycles (for KISS1, KISS1R, ERα and ERβ). Tubes lacking template cDNA or reverse
transcriptase (no amplification control) were included as negative controls.
Immunoprecipitation of kisspeptins from supernatant of cultured
placental explants
Isolation of KPs from placental explants culture supernatants was performed by Dynabeads M-
280 Tosylactivated (Invitrogen, USA) according the manufacturer’s recommendations. In
brief, magnetic beads were washed and coupled with 100 μg anti-KP-54 for 22 hr at 37°C. After
successive washing steps of beads, 1 mL placental explant supernatant was added to the ligand-
coupled beads for 90 min. Supernatant was removed on magnet and immediately frozen at
-80°C as KP-free conditioned medium (CM-w/o KP).
SDS-PAGE andWestern blotting
The presence of KPs in placenta tissues, supernatants collected from placental explants and
MDA-MB-231 and MCF-7 cell cultures were assessed by Western blotting according to the
procedure described elsewhere[23]. In brief, tissue and cell lysates were prepared using RIPA
lysis buffer (Santa Cruz, USA). Lysates were cleared by centrifugation at 12000 g for 15 min
and their protein contents were measured by BCA protein assay kit (Pierce, USA) per manu-
facturer’s recommendation. Placental explants supernatants were processed without any
manipulation. Proteins in lysates or supernatants were fractioned electrophoretically by 15%
SDS-PAGE under reducing condition and blotted on a nitrocellulose membrane (Millipore,
USA). The membrane was blocked in 5% non-fat dry milk (Merck, Germany) containing
0.05% Tween 20 overnight at 4°C. After washing steps, the membrane was incubated with anti-
KP-54 diluted 1:7500 in 5% non-fat dry milk for 90 min at RT. Membrane was then washed
and probed with horseradish peroxidase (HRP)-conjugated sheep anti-rabbit Ig (1:5000)(Sina
Biotech, Tehran, Iran) for 1 hr at RT followed by washing steps. Signals were visualized by ECL
Western Blotting Detection Reagents (GE Healthcare, Sweden) according to the manufactur-
er’s instruction. For blotting of synthetic KP-10, 18% SDS-PAGE was used followed by the
same procedure mentioned above. Negative control lanes received non-immune rabbit IgG
with the same concentration as anti-KP-54 instead of primary antibody.
Detection of kisspeptins in supernatants of cultured placental explants
by ELISA
Wells of microtiter polystyrene strips (Maxisorp, Nunc, Denmark) were coated with 10 μg/mL
of anti-KP-54 in a volume of 100 μL, for 2 hr at 37°C. Negative control wells received PBS as
Table 1. Sequence and annealing temperatures of the primers used in this study.
Forward (50–30) Reverse (50–30) Annealing Temp(°C)
KISS1 TGTACAACCTGCTGGCGCTG CCAGTTGTAGTTCGGCAGGT 62
GRP54 CACTTTGGGGAGCCATTAGA CCACTGCTCCCTGGCTTCTG 63.2
ER-α AGACATGAGAGCTGCCAACC GCCAGGCACATTCTAGAAGG 63
ER-b TCACATCTGTATGCGGAACC CGTAACACTTCCGAAGTCGG 63
β- actin AGCCTCGCCTTTGCCGA CTGGTGCCTGGGGCG 60
doi:10.1371/journal.pone.0153684.t001
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coating material. Strips were then washed three times with PBS-Tween (0.05%) (PBS-T) and
blocked using PBS containing 2.5% BSA and 10% FBS overnight at 4°C. After washing as above,
100 μL supernatants of cultured placental explants were added to the wells for 90 min at 37°C.
Some wells received culture medium as further negative controls. Wells were thoroughly washed
with PBS-T and treated with 500 ng/mL biotinylated anti-KP-54 (biotinylation was conducted in
ARI) for 30 min at 37°C. Washing step was proceeded as above followed by addition to the wells
of 1:12500 dilution of HRP-Streptavidin (Invitrogen, USA) for 30 min at 37°C. After the last
washing step, reaction was visualized using TMB chromogen (USB, USA) and optical densities
were recorded by an ELISA reader (Anthos 2020, Cambridge, England) at 450 nm.
Cell proliferation assay
Measurement of cell proliferation was performed as with protocol we published recently with
some modifications[24]. Briefly, linearity of measurement was first confirmed by seeding
increasing numbers of MDA-MB-231 and MCF-7 cells into the wells of a 96-well plate. Based
on the results, cell density of 4×103 cells/well, corresponding to the lower part of linear portion
of standard curve, was selected. Cells were seeded at aforesaid density and treated with different
media as below: final dilutions of 1:2, 1:4 and 1:8 of CM or CM-w/o KP, 1:2, 1:4 and 1:8 dilu-
tions of CM plus 20 μg/mL anti-KP-54 or the same concentration of normal rabbit IgG, culture
medium alone or containing either 20 μg/mL anti-KP-54, normal rabbit IgG or 100 nM KP-10
(Sigma). All treatments were performed in six replicas. Cultures were continued for 24, 48 and
72 hr and the extent of proliferation was measure by Propidium Iodide (PI) fluorometric assay.
At each time point, cells were lysed by 0.2% Triton X100 for 30 min on a shaker. DNA content
of lysed cells was stained in the dark for 15 min with 3 mM PI (Sigma). Fluorescent intensity of
the wells was measured by Victor IIX multilabel plate reader (PerkinElmer, USA) at excitation
and emission wavelength of 531 nm 595 nm, respectively.
Adhesion Assay
Attachment of MDA-MB-231 and MCF-7 cells to fibronectin-coated wells (BD biosciences,
USA) was assessed as described recently[25]. Briefly, a predetermined optimal cell number of
2.5×104/well MDA-MB-231 or 5×105/well MCF-7 was seeded into the wells of attachment
plates in DMEM containing 5% FBS. Immediately, cells were treated with different media as
stated above for cell proliferation assay. All treatments were performed in five replicas. Plates
were incubated for 150 min at CO2 incubator. Thereafter, non-adherent cells were removed by
gentle washing and adherent cells were fixed with 96% ethanol and stained with 0.1% crystal
violet. At the next step and in order to extract crystal violet, cells were lysed with 10% (v/v) ace-
tic acid and optical density of the wells were read using Anthos 2020 ELISA reader at 570 nm.
Cell Invasion Assay
The protocol for cell invasion assay was adapted from the recent paper by Nikoo et al.[26].
Briefly, invasive MDA-MB-231 and non-invasive MCF-7 cells were plated in the Matrigel-
coated upper chamber of 24-well invasion plates (8 μm pores) (BD biosciences, USA) at a den-
sity of 25000 cells/well. Lower chambers contained DMEM supplemented with 5% FBS as che-
moattractant. Cells were treated either with 1:2 dilution of CM or CM-w/o KP. In order to
implicate the role of the KISS1R in modulating the process of MDA-MB-231 invasion by pla-
cental KPs, some wells were treated with 1 μMKISS1R antagonist, P-234 (PHOENIX PHAR-
MACEUTICALS, USA, a gift from Dr. Mahmoudi, Shahid Beheshti University) three hours
before and also during treatment with CM. Some wells were also treated with 100 nM KP-10 or
medium without supplement. All treatments we performed in duplicate. Incubation for
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MDA-MB-231 and MCF-7 cells was continued at a CO2 incubator for 22 hr and 48 hr, respec-
tively. Cells remained in the upper side of the invasion filter were carefully scrapped off by a
pre-wet cotton swab and invading cells to the lower surface of the filter were fixed in methanol
and stained with 1% crystal violet. Filters were carefully removed and mounted on glass slides.
Invading cells were enumerated in 50 random fields using an Olympus BX51 microscope and
expressed as percentage of corresponding controls.
Gelatin zymographic detection of MMP2 and MMP9
MBA-MD-231 and MCF-7 cells cultured in serum-free medium were treated with CM, CM-w/
o KP or KP-10 for 24 hr. Untreated cells and cells treated with Phorbol 12-myristate 13-acetate
(PMA) served as negative and positive controls, respectively. Following treatments, cell culture
supernatants were collected on ice and centrifuged to remove cell debris. No procedure was
applied to concentrate supernatants. Protein contents of supernatants were determined by
Bradford method. A volume containing equal amount of protein from collected supernatants
was mixed with SDS sample buffer and applied without boiling to 10% SDS polyacrylamide gel
copolymerized with 1 mg/ml gelatin (Sigma-Aldrich). After electrophoresis, gels were washed
with gentle agitation in renaturing buffer (2.5% Triton X-100 in H2O) to remove SDS for 30
min at RT. The gels were then equilibrated in developing buffer (50 mM Tris, 200 mMNaCl, 5
mM CaCl2, pH, 7.5) at RT with gentle agitation for 30 min. After removing the old developing
buffer, the gels were incubated in fresh developing buffer at 37°C overnight. The gels were then
stained with 0.5% Coomassie Brilliant Blue and destained. The MMP activities were visualized
as clear bands against the blue background of the stained gels.
Wound healing assay for cell motility
Wells of 24-well plated were coated with 10 μg/mL fibronectin (Sigma) and seeded with
MDA-MB-231 and MCF-7 cells(50×104 cell/well) in DMEM containing 5% FBS. Cells were
allowed to grow to confluency for up to 48 hr and then serum-starved in DMEM-2% FBS, over-
night. On the bottom of the each well a line was drawn with a marker pen. Two straight parallel
lines of scratch, perpendicular to the marker line, were made through the cells using sterile
blue pipette tips followed by gentle washing with warm culture medium and treatment in
duplicate with 1:2 dilutions of CM, or CM-w/o KP, 100 nM KP-10 or culture medium all con-
taining 2% FBS. Some wells were pretreated with P-234 as described in invasion assay. To see
the effect of estrogen receptor signaling on modulation of cell motility after treatment with
CM, some MCF-7 wells were treated with selective ER modulators, Tamoxifen (100 nM) or
Raloxifene (1 nM) (both from Iran Hormone, gifted by Dr. Mohamaddi from Avicenna
Research Institute) for 24 hr before and during treatment with CM. Negative control wells
received vehicle (Methanol for Tamoxifen and DMSO for Raloxifene) with the same concen-
trations. Cells were allowed to migrate into the scratch for 30 hr and visualized at time intervals
of 0, 2, 4, 6, 12, 22 and 30 hr post-scratch. At each time period, four photographs (just below
and just above of crossing point of each scratch line with marker line) were captured from each
well. Percent of reduction in scratched areas at each time point compared to initial time point
was measured and analyzed using Image J software (http://imagej.nih.gov/ij) and plotted ver-
sus time. At the end of culture period, all supernatants were collected, centrifuged and stored at
-80°C for cytokine assay.
Cytokine assay
Concentrations of IL-6 and IL-8 in supernatants obtained at the end of wound healing assay
were measured by capture ELISA according to the manufacturers’ recommendations (BD
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biosciences). For each individual cytokine, optical densities were converted to concentration
after plotting the corresponding standard curve. The minimal detection limit for IL-6 and IL-8
assay kits was 3.1pg/mL.
Fig 1. Kisspeptin expression by human term placenta. A) Sections of human term (TP) and first trimester (FTP) placenta were double stained with anti-
Kp-54/Kp-145 and anti-CK7, a syncytiotrophoblast (STB) marker. Nuclei were counterstained with DAPI. Kisspeptin was mainly localized to apical and basal
surfaces of the STBs. B) Isolated cytotrophoblasts failed to express KISS1. A contaminating positive cell, most probably a STB, has been shown by white
arrow. In negative control slides, primary antibody was substituted by non-immune rabbit sera. C) Western blotting of FTP and TP (from three placentas
denotes as TP1-3). Lysates were probed with anti-Kp-54/Kp-145 antibody. The antibody produced one prominent band at ~15–16 kDa, which is in good
agreement with the calculated MW for Kp-145 (15.391 kDa). With purified Kp-10, anti-Kp-54/Kp-145 produced a single band at about 1.5 kDa, which is in
good agreement with the theoretical MW for Kp-10-13. β-actin served as loading control. D) Western blotting of conditioned medium (CM) collected from
cultured term placental explants at different time points (1–72 hr). KP was released from placental explants in as early as 1 hr after initiation of culture, peaked
at 4–6 hr and then progressively decreased until 72 hr. No KISS1-specific band was observed after KP removal (CM-w/o KP) by immuno precipitation. E)
RT-PCR analysis of KISS1expression in total RNA freshly isolated from TP (representative experiment). β-actin served as loading control. No amplification
controls (NAC) always were shown to be negative. The presence of KPs in CM was also confirmed by capture ELISA using two fold serially-diluted CMs. The
results showed a positive correlation between CM concentration and OD (Fig 1F). Results are representative of 11 term and 3 first trimester placentas. KPs:
Kisspeptin, CK7: Cytokeratin 7, TP: Term placenta, FTP: First trimester placenta, NC: Negative control. Scale bar: A; 100 μm, B; 50μm.
doi:10.1371/journal.pone.0153684.g001
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Statistical analysis
Differences in mean values between groups were analyzed with the Mann-Whitney U test for
comparison of 2 groups and the Kruskal-Wallis test with a Dunnett’s posthoc test for compari-
son of 3 or more groups using GraphPad Prism 4 (GraphPad Software, Inc.). Differences were
considered significant when p0.05.
Results
Human term placenta expresses high levels of kisspeptin
In this study, we collected eleven placental units from healthy pregnant women at the time of
cesarean delivery and surveyed expression of KPs at both gene and protein levels. To have a
rough estimate of how much expression of KPs is down regulated at term pregnancy, when tro-
phoblast invasion is considerably lost, three first trimester placentas from women undergoing
elective termination of pregnancy were collected and the expression of KPs was compared with
that of term placentas. For immunolocalization of KPs, a rabbit polyclonal antibody raised
against KP-54 was used with confirmed immunoreactivity against KP-145 and KP-54[7]. Dou-
ble color staining of placental sections with anti-KP-54 and CK7 clearly showed that human
term syncytiotrophoblasts (STB) expressed KPs at high level. KPs were mainly localized to cell
membrane of STBs at both apical and basal surfaces and also to the cell cytoplasm. Notably,
KPs were co-localized with CK7, a STB-specific marker. Other cell types including cytotropho-
blast cells (CTBs) failed to express KPs (Fig 1A). To confirm this result, CTBs were isolated
and individually tested for the expression of KPs. In line with the aforementioned results, no
expression of KPs was observed in isolated CTBs (Fig 1B). Although no quantitative measure-
ment was performed, comparative analysis of KPs expression by immunefluorescent staining
demonstrated that KPs signal in individual STBs of term placenta was lower compared to that
of first trimester placenta (Fig 1A). Indeed, expression of KPs in term placenta was found to be
of patchy pattern in which only some areas were positive, while expression pattern in first tri-
mester was more diffuse. We showed here using Western blotting that anti-KP-54 antibody
was also able to recognize purified KP-10, albeit with lower reactivity. In this case, a single
band of about 1.5 KDa was observed which is in good agreement with the theoretical MW for
KP-10, 13 or 14 (Fig 1C). Western blot analysis showed that human term placenta expresses
KP-145 (MW = 15.4 KDa) (Fig 1C). First trimester placenta expressed higher levels of KP con-
firming the results mentioned above (Fig 1C). Placental expression of KISS1 was checked by
RT-PCR. Results of this experiment clearly showed term human placenta expresses KISS1 tran-
script (Fig 1E).
Term placental kisspeptins are released in soluble form
In order to investigate whether or not term placental KPs are released in soluble form, placental
explants were cultured and the presence of KPs in the conditioned media was monitored at dif-
ferent time intervals of 1–72 hr. At all time points examined, specific band of KP-145 was
observed by Western blotting. Interestingly, KPs were released from placental explants in as
early as 1 hr after initiation of culture. The level of release was increased till 4 hr, and then pro-
gressively decreased until 72 hr (Fig 1D). Based on these results, in all subsequent experiments;
supernatants of placental cultures were collected 4 hr after explantation. The presence of KPs
in CM was also checked by capture ELISA using two fold serially-diluted CMs (from 1:1–1:8)
to see whether optical densities (OD) of the wells are titrated as well. As negative control, corre-
sponding CMs without KPs were run in parallel. The results showed a positive correlation
between CM concentration and OD confirming that our ELISA system technically works (Fig
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1F). To prepare KP-free conditioned medium, KPs was removed from placental explants cul-
ture supernatants by immunoprecipitation. No KP-specific band was observed after KP
removal indicating high efficacy of purification system (Fig 1D).
MDA-MB-231 and MCF-7 cells express KISS1mRNA but not protein
To find out how the cancerous vital parameters of breast cancer cells is affected by placental-
derived KPs and having considered the central role of ER expression on biology of most
human breast cancer cell types, expression of ERα, ERβ, KISS1 and KISS1R were investigated
by RT-PCR. MCF-7 and MDA-MB-231 cells expressed transcripts of KISS1 and KISS1R. For
confirmation, expression of KPs at the protein level was surveyed by two independent experi-
ments, immunofluorescent staining and Western blotting. In spite of positive results for KISS1
transcript (Fig 2B), KPs were not found to be expressed at protein level in both cell types (Fig
2A and 2C). As expected, ERα and ERβ were expressed by MCF-7 cells, but MDA-MB-231
cells failed to express these receptors (Fig 2B).
Placental kisspeptins inhibit proliferation of breast cancer cells
Potential inhibitory activity of placental KPs on proliferation of MDA-MB-231 and MCF-7
breast cancer cells was monitored over three days. According to the results, supernatants con-
taining KPs significantly reduced proliferation of both cell lines compared to CM-w/o KP
(p<0.05–0.001, depending on CM dilution and culture period) (Fig 3). Specific inhibitory
Fig 2. Characterization of ERα, ERβ, KISS1 and KISS1R expression by MDA-MB-231 andMCF-7 breast cancer cells. A) Immunofluorescent staining
of MDA-MB-231 and MCF-7 breast cancer cells with anti-Kp-54/Kp-145 showing no KP-specific signal. Nuclei were counterstained with DAPI. In negative
control slides, primary antibody was substituted by non-immune rabbit sera. B) RT-PCR of total RNA of MDA-MB-231 and MCF-7 cells. β-actin served as
loading control. MDA-MB-231 and MCF-7 cells expressed KISS1 and KISS1R transcripts. No amplification controls (NAC) always were shown to be
negative. C) Western blotting of MDA-MB-231 and MCF-7 for KP expression. No KISS-1-specific band was detected. Term placenta (TP) lysate served as
positive control. ER: Estrogen receptor, KISS1R: KISS1 receptor, NC: negative control, KP: Kisspeptin. Scale bare: 50μm.
doi:10.1371/journal.pone.0153684.g002
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action of placental KPs on proliferation of the cells, was shown by adding anti-KP-54 to the
CM-treated cells, which resulted in significantly restored proliferation of both cell lines treated
with 1:2 dilution of CM (p<0.05)(Fig 3A and 3B). Such activity of anti-KP-54 was due to the
specific neutralization of soluble KPs, as addition of anti-KP-54 or the same concentration of
normal rabbit IgG to the culture medium did not affect proliferation rate of the cells. 1:2 dilu-
tions of CM exhibited anti-proliferative activity at all time intervals (p<0.05–0.001). Higher
dilutions of CMs, however, gradually lost their anti-proliferative activity over time compared
to the same dilutions of CM-w/o KP. Interestingly, 1:2 dilution of CM-w/o KP increased prolif-
eration of MCF-7 cells in 24 and 48 hr culture periods (p<0.05) (Fig 3B), but such prolifera-
tion-stimulatory effect did not last for 72 hr. Contrary to MCF-7 cells, different dilutions of
CM-w/o KP caused a significant inhibitory effect (p<0.05–0.001) on MDA-MB-231 cells
which was more prominent at 48–72 h culture periods (Fig 3A). At the next step, we examined
the effect of synthetic KP-10 on proliferation of breast cancer cells. In both cell types, 100 nM
KP-10 exerted anti-proliferative activity in 24 and 48 hr culture periods (p<0.05–0.01), but no
anti-proliferative activity was observed after 72 hr (Fig 3A and 3B).
Placental kisspeptins reduces adhesive properties of MDA-MB-231 cells
At the next step, potential effect of placental KPs on adhesion of breast cancer cells to extracel-
lular matrix was examined. Cells were seeded in fibronectin-coated wells for 150 min and dif-
ferentially treated with different media listed in proliferation assay. The level of attachment
was then measured photometrically. Compared to CM-w/o KP, 1:2 dilution of CM signifi-
cantly reduced adhesive properties of MDA-MB-231 cells (p<0.05)(Fig 4A). However, no sig-
nificant effect was observed when MCF-7 cells were treated with CM. KP-10 exerted no
significant effect on adhesion of both breast cancer cell lines.
Placental kisspeptins potentiates invasiveness of MDA-MB-231 cells
At the next step, we examined whether placental KPs alter invasive potential of MDA-MB-231
and MCF-7 cells using Matrigel invasion assay. Cells were seeded on Matrigel-coated filters
and allowed to invade across the Matrigel towards FCS. To find possible effect of placental KPs
on invasive properties of the cells, CM containing KPs was added to the cells at final dilution of
1:2 during culture period. Cells treated with CM-w/o KP served as negative control. We
observed that MDA-MB-231 cells treated with CM exhibited significantly higher invasiveness
compared to those treated with the same dilution of corresponding CM-w/o KP(p<0.001). Co-
treatment of the cells with P-234 and CM normalized the rate of cell invasion to the levels
observed in cells treated with CM-w/o KP (Fig 5Aa and 5Ab). In parallel, KP-10 significantly
stimulated MDA-MB-231 cell invasion towards FCS (p<0.05) (Fig 5Aa and 5Ab). Neither CM
nor KP-10 did significantly alter invasive property of MCF-7 cells (Fig 5Ba and 5Bb). To find
out the basis of increased invasiveness of MDA-MB-231 cells following treatment with CM,
gelatin zymography was performed. Accordingly, we found that MDA-MB-231 cells treated
with CM released higher amounts of MMP2 and MMP9 compared to those treated with either
Fig 3. Effect of term placental kisspeptins on proliferation of MDA-MB-231 andMCF-7 breast cancer cells.MDA-MB-231 (A) and MCF7 (B) cells were
treated with different media as indicated in the figure for 24, 48 and 72 hr. All treatments were performed in six replicas. The extent of proliferation was
measured by Propidium Iodide (PI) fluorometric assay. Significant differences were analyzed by Kruskal-Wallis test with a Dunnett’s posthoc test. Different
dilutions from 1:2 to 1:8 were tested. CM: Term placenta conditioned medium containing KP, CM-w/o KP: KP-free CM, anti-KP: anti-Kp-54/Kp-145 antibody,
Rb Ig: Rabbit immunoglobulin, Medium: Culture medium alone, KP: Kisspeptin. Results are representative of 7 term placentas. * CM vs. CM-w/o KP(p<0.05–
0.01 for MDA-MB-231 and p<0.05–0.001 for MCF-7), φ CM vs. medium (p<0.01–0.001 for MDA-MB-231 and p<0.05–0.01 for MCF-7), βCM vs. CM+anti-
KP-10 (p<0.05–0.01 for MDA-MB-231 and p<0.05 for MCF-7),Φ CM-w/o KP vs. medium (p<0.05–0.001 for MDA-MB-231 and p<0.05 for MCF-7), ψ KP-10
vs. medium (p<0.05–0.01 for MDA-MB-231 and p<0.05–0.01 for MCF-7).
doi:10.1371/journal.pone.0153684.g003
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CM-w/o KP. In parallel, cells treated with KP-10 showed slightly higher MMP9 activity in
comparison to cultured in medium alone. Interestingly, supernatant of cultured term placental
explants failed to express detectable levels of MMP2 and MMP9 activities (Fig 5C).
Motility of MDA-MB-231 and MCF-7 cells is inversely affected by
placental kisspeptins
Wound healing assay is a well-developed method to study directional cell migration in vitro. In
this context, we conducted a tightly controlled in vitro scratch assay to investigate the effect of
placental KPs on motility of breast cancer cell lines in two-dimensional culture system. Cell
motility was monitored from initiation of culture and continued for 30 hr. To avoid any bias in
determining motility rate due to possible variety in scratch diameters, reduction percent of
scratch diameter in each well at different time intervals was calculated relative to the scratch
diameter of the same well at time 0. We found that CM containing KPs significantly reduced
motility of MCF-7 cells at all time points compared to CM-w/o KP(p<0.05–0.001)(Fig 6B).
Supernatants of cultured placental explants whether contained KP (CM) or not (CM-w/o KP)
Fig 4. Effect of term placental kisspeptins on adhesion of MDA-MB-231 andMCF-7 breast cancer
cells.MDA-MB-231 (A) and MCF-7 (B) cells were treated with different media as indicated in the Fig 3 for 150
min and their adhesion to fibronectin-coated plates was assessed by a colorimetric assay. Different dilutions
from 1:2 to 1:8 were tested. CM: Term placenta conditioned medium containing KP, CM-w/o KP: KP-free CM,
anti-KP: anti-Kp-54/Kp-145 antibody, Rb Ig: Rabbit immunoglobulin, Medium: Culture medium alone, KP:
Kisspeptin. Results are representative of 11 term placentas. *CM vs. CM-w/o KP(p<0.05 for MDA-MB-231).
doi:10.1371/journal.pone.0153684.g004
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exerted an intense inhibitory action on MCF-7 cell motility during entire culture period
(p<0.001–0.0001). Such inhibitory activity was evident as early as 2 hr and lasted until the end
of culture period (Fig 6). In parallel to the placental KPs, KP-10 also significantly reduced
MCF-7 cell motility at all time intervals (p<0.01–0.001). Conversely, MDA-MB-231showed
significantly stimulated motility after treatment with CM containing KPs (p<0.05–0.001) (Fig
6A). Such effect was more evident at 6 hr, after which stimulatory activity of placental KPs on
cell motility was gradually subsided till 30 hr, when no statistical difference was found in cell
Fig 5. Effect of term placental kisspeptins on invasiveness of MDA-MB-231 and MCF-7 breast cancer cells.MDA-MB-231 (A) and MCF-7 (B) cells
were treated with supernatants of cultured term placental explants containing KP (CM), CM plus 1 μMKISS1R antagonist; P-234, KP-free CM (CM-w/o KP),
KP-10 or culture medium alone and their invasion toward chemo attractant (FCS) through Matrigel-coated filters was investigated. Invading cells was
enumerated in 50 random fields (Ab and Bb) and expressed as percentage of corresponding controls (Aa and Ba). C) Gelatin zymographic analysis for matrix
metalloproteinase (MMP) expression. MDA-MB-231 cells treated with CM released higher amounts of MMP2 and MMP9 compared to those treated with
either CM-w/o KP. In parallel, cells treated with KP-10 showed slightly higher MMP9 activity in comparison to cultured in medium alone. Cells treated with
Phorbol 12-myristate 13-acetate (PMA) served as positive control. CM failed to express detectable levels of MMP2 and MMP9. Results of two (denoted by
numbers) out of four samples are shown. KP: Kisspeptin, MW: Molecular weight.
doi:10.1371/journal.pone.0153684.g005
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motility of the cells treated with CM compared to those treated with CM-w/o KP. In contrast
to MCF-7 cells, both placental explant culture supernatants containing KPs (CM) or lacking it
(CM-w/o KP) intensely increased MDA-MB-231 cell motility (p<0.01–0.001) (Fig 6A). The
most intensive stimulatory activity on motility of MDA-MB-231 cells was observed at 6 hr.
Comparable to the action of placental KPs, KP-10 exerted considerable stimulatory activity on
motility of MDA-MB-231 cells (p<0.05–0.01) (Fig 6A). The effects of CM on motility of breast
cancer cells were reversed by P-234 (p<0.05) (Fig 6Ac and 6Bc). In parallel, co-treatment
with selective ER modulators inhibited the effect of CM on motility of MCF-7 cells (p<0.05)
(Fig 6Bc).
Placental kisspeptins modulates pro-inflammatory cytokine production
by breast cancer cells
IL-6 and IL-8 are among pro-inflammatory cytokines with profound effects on biology of can-
cer cells. We therefore investigated whether the production of these cytokines by breast cancer
cells are affected by placental KPs. To this end, concentrations of these cytokines were mea-
sured in culture supernatants of breast cancer cells treated with CM, CM-w/o KP, KP-10 or
culture medium. To exclude overlap of placental-derived cytokines with those produced by
breast cancer cells, we also measured cytokine levels in CM and CM-w/o KP. To avoid any bias
due to decomposition of placental cytokines during treatment period of breast cancer cells (30
hr), CM and CM-w/o KP were first incubated for 30 hr in CO2 incubator before measurement
of cytokine levels. We observed that CM and CM-w/o KP contained considerable amount of
IL-6 indicating production of this cytokine by placental villi. No detectable levels of IL-6 were
found to be produced by MCF-7 cells. Concentration of IL-6 in supernatant of MCF-7 treated
with either CM or CM-w/o KP was significantly lower compared to that in CM or CM-w/o KP,
respectively (p<0.001) (Fig 7B). Compared to the cells treated with CM-w/o KP, there was
higher concentration of IL-6 in cells treated with CM (p<0.05). KP-10 did not exert any signif-
icant effect on IL-6 production by MCF-7 cells (Fig 7B). In contrast to MCF-7 cells, MDA-MB-
231 cells produced very high levels (at nanogram scale) of IL-6. Both CM and CM-w/o KP
caused high production of IL-6 by MDA-MB-231 cells (p<0.001) (Fig 7A). A slight but signifi-
cant increase in IL-6 production was observed when MDA-MB-231 cells were treated with KP-
10 (p<0.05)(Fig 7A). Both CM and CM-w/o KP contained high amounts of IL-8. The level of
IL-8 in supernatant of MDA-MB-231(p<0.01) and MCF-7 (p<0.0001) cells treated with CM
was higher compared to that in CM (Fig 7A and 7B). Cells treated with CM produced more IL-
8 compared to those treated with CM-w/o KP (p<0.01). KP-10 increased IL-8 production by
MDA-MB-231(p<0.05) and MCF-7 (p<0.05) cells (Fig 7A and 7B).
Discussion
Thus far, anti-cancer activity of KPs has been demonstrated in numerous cancers[27]. In case
of breast cancer, however, there are rather limited and somehow conflicting data on KP-
Fig 6. Effect of term placental kisspeptins onmotility of MDA-MB-231 and MCF-7 breast cancer cells.MDA-MB-231 (A) and MCF-7 (B) cells were
treated with supernatants of cultured term placental explants containing KP (CM), KP-free CM (CM-w/o KP), KP-10 or culture medium alone and their
migration toward scratch was monitored during a period of 30 hr. Representative photographs are shown in Aa (MDA-MB-231) and Ba (MCF-7). Percent of
reduction in scratched areas at each time point compared to initial time point was measured and analyzed using Image J software (Ab for MDA-MB-231 and
Bb for MCF-7). Treatment with P-234 reversed the effect of CM on motility of MDA-MB-231 (Ac) and MCF-7 (Bc). Co-treatment with selective ERmodulators
inhibited the effect of CM on motility of MCF-7 cells (Bc). * CM vs. CM-w/o KP (p<0.05–0.001 for MDA-MB-231 and p<0.05–0.001), φ CM vs. medium
(p<0.01–0.001 for MDA-MB-231 and p<0.001–0.0001 for MCF-7),ψ KP-10 vs. medium (p<0.05–0.01 for MDA-MB-231 and p<0.01–0.0001 for MCF-7),? CM
vs. CM-w/o KP and CM+P-234 (p<0.05),? CM-w/o KP, CM+P-234, CM+100 nm Tam and CM+1 nm Ral vs. CM (p<0.05). Results are representative of 4 term
placentas. Tam: Tamoxifen, Ral: Raloxifene.
doi:10.1371/journal.pone.0153684.g006
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mediated modulation of cancer cell vital parameters including proliferation, migration, inva-
sion and adhesion; mainly based on synthetic KP-10, the most active fragment of KPs. Here,
we report for the first time the effects of the activity of placental KPs on proliferation, invasion,
motility, adhesion and cytokine production in ER-negative and ER-positive breast cancer cells.
Contrary to what was reported earlier[7], we showed that term placenta expresses KPs, mostly
restricted to the syncytiotrophoblast surface of villi. In Western blot analyses, polyclonal anti-
body generated against KP-54, which is a part of KP-145, detected KP-145 in first trimester
and term placental lysate and CM, but not other variants of KPs. Negative results for smaller
fragments of KPs was not due to the nonreactivity of anti-KP-54 against these fragments, we
Fig 7. Effect of term placental kisspeptins on cytokine production by MDA-MB-231 andMCF-7 breast cancer cells.Concentrations of IL-6 and IL-8
were measured in culture supernatants of MDA-MB-231 (A) and MCF-7 (B) cells treated with CM, CM-w/o KP, KP-10 or culture medium. To exclude overlap
of placental-derived cytokines with those produced by breast cancer cells, we also measured cytokine levels in CM and CM-w/o KP. $ Cell + CM vs. Cell
+ CM-w/o KP[(IL-6: p<0.05 for MCF-7), (IL-8: p<0.01 for MDA-MB-231 and p<0.01 for MCF-7)], ε Cell + CM vs. CM [(IL-6: p<0.001 for both breast cancer
cells), (IL-8: p<0.01 for MDA-MB-231 and p<0.0001 for MCF-7)], μ Cell + CM vs. Cell + medium [(IL-6: p<0.05 for MDA-MB-231), (IL-8: p<0.05 for MDA-MB-
231 and p<0.01 for MCF-7)],Ω Cell + CM-w/o KP vs. Cell + medium [(IL-6: p<0.05 for MDA-MB-231), (IL-8: p<0.05 for MDA-MB-231 and p<0.01 for MCF-7)],
δ Cell + CM-w/o KP vs. CM-w/o KP[(IL-6: p<0.001 for MDA-MB-231, p<0.001 for MCF-7), (IL-8: p<0.01 for MDA-MB-231 and p<0.0001 for MCF-7)], ψCell
+KP-10 vs. Cell + medium [(IL-6: p<0.05 for MDA-MB-231), (IL-8: p<0.05 for MDA-MB-231 and p<0.05 for MCF-7
doi:10.1371/journal.pone.0153684.g007
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showed that anti-KP-54 is able to detect purified KP-10 inWestern blotting and its reactivity
against KP-54 with the same methodology has already been documented[7]. This may be in part
due to the rapid degradation of intracellular KP-54 because of the presence of PEST sequences
predisposing KP-54 to proteosome degradation[28]. But the most probable scenario is that levels
of intra- or extracellular KP-54 or smaller KP fragments are below the detection limit of western
blotting as Bilban et al. [7] using MALDI-TOF showed that first trimester placenta conditioned
medium contained KP-10, 13,14 as well as KP-54 in spite of failure to detect these variants in the
same medium withWestern blotting. Expression of KPs by term placenta in spite of very low
level expression of MMPs and no/low invasiveness of trophoblasts indicates that KPs may be
involved in other molecular mechanisms besides their role in invasion control.
Allthough KISS1mRNA is expressed by MDA-MB-231 and MCF-7 cells, no KISS1-specific
signal was detected in Western blotting or immunofluorescent staining. Presumably, KP-145
associated with breast cancer cells undergoes rapid degradation by furin or prohormone con-
vertases. This suggestion is supported by the fact that breast cancer tissues and cell lines includ-
ing MDA-MB-231 and MCF-7 express elevated levels of furin and other members of the pro-
protein convertase[29].
We next evaluated potential effect of placenta KPs on proliferation of MCF-7 and
MDA-MB-231 breast cancer cells. Data on modulatory effect of KP-10 on breast cancer cell
proliferation are limited and generally show no association between KP-10 stimulation and
cancer cell growth. In a paper published by Kostadima et al.[30], no association of KISS1
expression was found with genes that regulate cell-cycle and proliferation such as HER2, VEGF
and p53. Indeed, it was shown that proliferation of breast epithelial or breast cancer cell lines
including MCF-7 and MDA-MB-231, expressing the receptor endogenously or exogenously,
was not affected by KP-10[30–32]. Our results clearly demonstrated that placental KPs
markedly reduced proliferation of breast cancer cells in a dose- and time-dependent manner,
regardless of ER status of cancer cells. This observation may be due to cumulative effects of dif-
ferent placental KPs fragments working in concert. Indeed, activity of the proteins is exten-
sively influenced by their structure and it is highly probable that placental KPs with native
conformation are more stable compared to synthetic polypeptides. In support of this hypothe-
sis, our results showed that placental KPs have higher potency to block cell proliferation in gen-
eral and retained its activity until 72 hr, when no anti-proliferative activity for KP-10 was
observed.
In sharp contrast to MDA-MB-231 cells, conditioned medium lacking KPs increased prolif-
eration of MCF-7 cells. Such reverse effects on cell proliferation can be interpreted in part by
differential responsiveness of MCF-7 and MDA-MB-231 to the estradiol produced by placenta.
It has been reported that 17β-estradiol inhibits MDA-MB-231 breast cancer cell growth by
increasing BAX/BCL-2 and reducing pERK1/2[33], while it is mostly agreed that it promotes
proliferation and cell-cycle progression of MCF-7 cells. More importantly, ER was shown to
have differential cross-talk with activation protein 1 (AP1) transcription factors in these cells
types; as it facilitates AP1 activity in MCF-7 cells, but inhibits their activity in such ER-cancer
cells as MDA-MB-231 cells[34].
Next, we observed that CM and KP-10 significantly reduced motility of MCF-7 cells com-
pared to CM-w/o KP. Notably, placental explant conditioned medium with or without KP-
exerted an intense inhibitory action on MCF-7 cell motility. The opposite was the case for
MDA-MB-231 cells, where CM-w/o KP and to a significantly higher degree CM increased
MDA-MB-231 cell motility. Available data on placental manipulation of breast cancer cell
migration and motility is mostly focused on first trimester placenta. In a recent work by Sho-
chet et al. and contrary to what we found, it was shown that first trimester placental superna-
tants increased migration of ER+ breast cancer cells, MCF-7 and T47D, in scratch assay and
Modulation of Breast Cancer Cells by Placental Kisspeptins
PLOS ONE | DOI:10.1371/journal.pone.0153684 April 21, 2016 18 / 23
that progesterone and E2 were significantly involved in mediating this effect[35]. The reason
behind such discrepancy is not clear for us but two hypotheses could be put forth. First, despite
availability of substantial information on the process of breast cancer metastasis, the role of ER
signaling in this process remains poorly understood. Some studies proposed a negative effect of
E2 on motility of ER+ breast cancer cells, while others showed a positive effect[34, 36, 37].
These diverging results may stem from dose-dependent action of E2 on cancer cell vital param-
eters[38] or from different methodologies used for assessment of cell motility. Notably, produc-
tion of E2 by placenta is steadily increased throughout the gestation resulting in a totally
different E2 concentration in supernatants of first trimester and term placental conditioned
medium. Secondly, according to the recent findings, more than half of the genes that are
expressed in the human placenta change their expression profile from the first to the third tri-
mester of pregnancy indicating a substantial molecular rearrangement of placenta during
development. Remarkably, genes involved in cell proliferation, cell differentiation and angio-
genesis were up-regulated in the first compared to third trimester placenta[39]. In an elegant
work conducted by Taylor et al., elegantly demonstrated that placental growth factor (PlGF)
enhanced motility of MDA-MB-231 cells by mobilizing ERK1/2 phosphorylation, rearrange-
ments of the actin cytoskeleton and stabilization of cytokeratin 19 and vimentin expression[40],
a finding which supports our results on increased migration of MDA-MB-231 cells following
treatment with placental supernatants. Interestingly, placental KPs exerted opposite effects on
migration and invasiveness of MCF-7 andMDA-MB-231 cells. Metastasis is a complex process
involving loss of cell-cell contact, invasion into neighboring tissues and spreading of tumor cells
to the distant tissues. Despite well-documented studies showing anti-metastatic action of KISS1/
KISSR signaling in numerous cancer types, the role of this system in breast cancer metastasis
remained controversial. Some reports shows positive correlation between KISS1mRNA expres-
sion or KISS1R signaling and breast cancer progression and metastasis[15, 16], while the results
of other reports indicate that KISS1 is required for metastasis suppression and maintenance of
tumor dormancy[30, 41–43].To elucidate such discrepancy, Cvetkovic´et al. examined potential
activity of KP-10 on estrogen receptor positive and negative cell lines and demonstrated that KP-
10 stimulates invasion of estrogen receptor negative MDA-MB-231 breast cancer cells via trans-
activation of the epidermal growth factor receptor (EGFR). They showed that KP-10-enhanced
invasiveness of MDA-MB-231 cells was ablated by exogenous expression of ERalpha. In sharp
contrast with ER negative cell line, neither transactivation of EGFR nor stimulation of invasive-
ness was observed when ER positive MCF-7 and T47D breast cancer cells were treated with
KP-10. This observation suggests that ER expression status may be a basis for whether or not
invasiveness and migration of breast cancer cells are affected by KISS1/KISS1R system [31]. In
line with this findings, Zajac et al. showed that KP-10 stimulated invasion and increased MMP9
activity in MDA-MB-231 breast cancer cells[44]. In order to test the effect of ER signaling on
reduced motility of MCF-7 cells following treatment with CM, we treated the cells with selective
ER modulators, Tamoxifen and Raloxifene, and found that such treatments could significantly
reverse the effect of CM on cell motility to the levels observed in cells treated with CM-w/o KP.
These results are in line with the previous reports showing the influence of ER signaling on KP
modulation of cell migration. Our findings also revealed that in parallel to KP-10, placental KPs
stimulated migration and invasion of KISS1+/KISS1R+/ER- MDA-MB-231 cells, a finding which
was concomitant with secretion of MMP9 andMMP2. Co-treatment of MDA-MB-231 cells with
KISS1R antagonist, P-234, and CM blocked CM-mediated increased invasiveness and motility of
these cells indicating that KISS1R is involved in regulating the process of cell invasion following
treatment of the cells with CM.
Interestingly, placental KPs markedly reduced migration potential of KISS1+/KISSR+/ER+
MCF-7 cells which was reversed by P-234. These findings reinforce the concept that it is ER
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status of breast epithelial cells that critically regulates the ability of KISS1R signaling to stimu-
late invasiveness. In fact, Olbrich et al. showed that bone-directed migration of MCF-7 cells is
inhibited by KP-10 through down-regulating the expression of chemokine receptor CXCR4
and its ligand, stromal derived factor (SDF)-1[45]. We found that placental KPs significantly
reduced adhesive properties of MDA-MB-231 cells, but exerted no effect on MCF-7 adhesion.
This finding supports our results on increased invasiveness of MDA-MB-231 cells following
treatment with CM containing KPs. KP-10, however, did not affect adhesiveness of both cells
types. According to previous reports, KP-10 does not affect overall rate of cell adhesion to
ECM and regulates events downstream of cell–matrix adhesion, perhaps involving cytoskeletal
re-organization[14].
Pro-inflammatory cytokines play an important role in breast cancer biology. Therefore, to
find a mechanistic basis of placental KP-modulation of breast cancer cells vital parameters, we
next examined whether or not production of IL-6 and IL-8 are affected by placental KPs. We
did not find any report connecting KPs and production of pro-inflammatory cytokines.
Whether or not differential effect of placental KP on pro-inflammatory cytokine production by
MCF-7 and MDA-MB-231 cells is under control of ER signaling, is not clear at present. But
there are some reports showing that ER impairs IL-6 expression by preventing protein binding
on the NF-κB site[46], a finding which is in line with our results for MCF-7. We showed that
CM, compared to CM-w/o KP, caused a significant increase in IL-6 concentration in superna-
tant of treated MCF-7 cells showing the positive effect of placental KPs in IL-6 levels. This find-
ing may be a basis for anti-proliferative effect of placental KPs as it was shown that direct
application of IL-6 on breast cancer cells inhibits proliferation in estrogen receptor positive
cells[47, 48]. Interestingly, proliferation of ER- breast cancer cells are not affected by IL-6 [47]
implying IL-6-independent modulation of ER- MDA-MB-231 cells proliferation. Moreover we
found that IL-6 expression by MDA-MB-231 cells is not affected by placental KPs. We also
observed that placental KPs increased IL-8 production by MDA-MB-231 and MCF-7 cells.
Interestingly, the invasion potential of ER- breast cancer cells is associated at least in part with
expression of IL-8 [49]. This data is in line with stimulatory action of placental KPs on invasive
capacity of MDA-MB-231 cells. On the other hand, this cytokine considerably induces migra-
tion of MDA-MB-231 cells, while inhibits migration of MCF-7 cells [50] Increased migration
of MDA-MB-231 cells and decreased migration of MCF-7 cells following treatment with pla-
cental KPs may be in part interpreted by stimulatory activity of placental KPs on IL-8 produc-
tion by these breast cancer cell types.
Collectively, here we reported the results of comprehensive analyses of placental KP-modu-
lation of breast cancer cells. The data presented here clearly showed that placental KP differen-
tially affected proliferation, invasion, adhesion, and motility of ER-negative and ER-positive
breast cancer cells possibly by modulation of pro-inflammatory cytokine production and that
in most instances such effects were in parallel to and in some instances stronger than what was
exerted by synthetic KP-10. Our results suggest that placental factors may reduce breast cancer
progression depending on ER status of cancerous cells and support the concept that it is the ER
status of mammary cells that dictates whether or not KISS1R may be a novel clinical target for
treating breast cancer metastasis.
Conclusion
Taken together, our observations suggest that placental KPs differentially modulate vital
parameters of estrogen receptor-positive and -negative BC cells possibly through modulation
of pro-inflammatory cytokine production.
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